Redell MS - Search Results

1

Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.

Stevens AM, Xiang M, Heppler LN, Tošić I, Jiang K, Munoz JO, Gaikwad AS, Horton TM, Long X, Narayanan P, Seashore EL, Terrell MC, Rashid R, Krueger MJ, Mangubat-Medina AE, Ball ZT, Sumazin P, Walker SR, Hamada Y, Oyadomari S, Redell MS, Frank DA. Stevens AM, et al. Among authors: redell ms. Blood Adv. 2019 Dec 23;3(24):4215-4227. doi: 10.1182/bloodadvances.2019000499. Blood Adv. 2019. PMID: 31856268 Free PMC article.

2

Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.

Redell MS, Ruiz MJ, Alonzo TA, Gerbing RB, Tweardy DJ. Redell MS, et al. Blood. 2011 May 26;117(21):5701-9. doi: 10.1182/blood-2010-04-280123. Epub 2011 Mar 29. Blood. 2011. PMID: 21447830 Free PMC article.

3

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.

Redell MS, Ruiz MJ, Gerbing RB, Alonzo TA, Lange BJ, Tweardy DJ, Meshinchi S; Children's Oncology Group. Redell MS, et al. Blood. 2013 Feb 14;121(7):1083-93. doi: 10.1182/blood-2012-04-421925. Epub 2012 Dec 14. Blood. 2013. PMID: 23243289 Free PMC article.

4

DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy.

Liu W, Deng L, Song Y, Redell M. Liu W, et al. PLoS One. 2014 May 23;9(5):e98270. doi: 10.1371/journal.pone.0098270. eCollection 2014. PLoS One. 2014. PMID: 24858818 Free PMC article.

5

Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.

Long X, Yu Y, Perlaky L, Man TK, Redell MS. Long X, et al. Among authors: redell ms. Br J Haematol. 2015 Sep;170(5):704-18. doi: 10.1111/bjh.13492. Epub 2015 May 14. Br J Haematol. 2015. PMID: 25974135 Free PMC article. Clinical Trial.

6

Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Stevens AM, Ruiz MJ, Gerbing RB, Alonzo TA, Gamis AS, Redell MS. Stevens AM, et al. Among authors: redell ms. Haematologica. 2015 Dec;100(12):e496-500. doi: 10.3324/haematol.2015.131508. Epub 2015 Aug 20. Haematologica. 2015. PMID: 26294728 Free PMC article. No abstract available.

7

Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.

Minus MB, Liu W, Vohidov F, Kasembeli MM, Long X, Krueger MJ, Stevens A, Kolosov MI, Tweardy DJ, Sison EA, Redell MS, Ball ZT. Minus MB, et al. Among authors: redell ms. Angew Chem Int Ed Engl. 2015 Oct 26;54(44):13085-9. doi: 10.1002/anie.201506889. Epub 2015 Sep 7. Angew Chem Int Ed Engl. 2015. PMID: 26480340 Free PMC article.

8

A STAT3 decoy lures AML out of hiding.

Redell MS. Redell MS. Blood. 2016 Mar 31;127(13):1628-9. doi: 10.1182/blood-2016-02-695452. Blood. 2016. PMID: 27034418 Free article.

9

CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.

Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, Gaikwad A, Nguyen P, Arber C, Song XT, Redell M, Gottschalk S. Bonifant CL, et al. Mol Ther. 2016 Sep 29;24(9):1615-26. doi: 10.1038/mt.2016.116. Epub 2016 Jun 6. Mol Ther. 2016. PMID: 27401038 Free PMC article.

10

Assessing the intracellular fate of rhodium(ii) complexes.

Minus MB, Kang MK, Knudsen SE, Liu W, Krueger MJ, Smith ML, Redell MS, Ball ZT. Minus MB, et al. Among authors: redell ms. Chem Commun (Camb). 2016 Sep 22;52(78):11685-11688. doi: 10.1039/c6cc05192h. Chem Commun (Camb). 2016. PMID: 27709185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page